Increased radiosensitivity and radiothermosensitivity of human pancreatic MIA PaCa-2 and U251 glioblastoma cell lines treated with the novel Hsp90 inhibitor NVP-HSP990.
about
Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor RadiosensitizationCytoplasmic HSP90α expression is associated with perineural invasion in pancreatic cancer.A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies.The combination of Hsp90 inhibitor 17AAG and heavy-ion irradiation provides effective tumor control in human lung cancer cells.Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer.Cytotoxicity of gemcitabine-loaded thermosensitive liposomes in pancreatic cancer cell lines.Radiosensitizers in pancreatic cancer--preclinical and clinical exploits with molecularly targeted agents.Hsp90 Inhibitor Ganetespib Sensitizes Non-Small Cell Lung Cancer to Radiation but Has Variable Effects with Chemoradiation.Current concepts in clinical radiation oncology.Strategies to relieve immunosuppression in pancreatic cancer.Realistic biological approaches for improving thermoradiotherapy.Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines.Biological determinants of radioresistance and their remediation in pancreatic cancer.Insights into molecular therapy of glioma: current challenges and next generation blueprintEfficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas.PAM-OBG: A monoamine oxidase B specific prodrug that inhibits MGMT and generates DNA interstrand crosslinks, potentiating temozolomide and chemoradiation therapy in intracranial glioblastoma.Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy
P2860
Q26771165-00EF04C4-9840-4458-BAD6-8EAF83C93631Q33898794-901F633F-17BE-4920-8D1A-745C100E9F4CQ35098333-AA5CBE3E-01B8-40A8-AC20-94949B324DC0Q35236805-36EAD0B7-A7E6-4359-A8AD-F7789712182DQ35727558-6F4B88EA-DE26-4F83-B92A-A1B5DF37D306Q35747497-08A0F6A6-A1E6-4783-8DB0-5E4305F5CEAEQ37403232-5983F339-E98E-4BF6-A61A-C49E6B8DFB09Q37470072-142E24F1-35E5-44B2-9C76-01244A89E63BQ37603804-05ADD5F4-5D48-4EA1-B9A6-0B2E7AC29160Q38445328-1192E2E0-3B5C-4DDE-ABF8-158ECBC18D97Q38648236-F3F8D359-C2B9-4279-87F2-D1ECDAC9A18EQ38868168-3F230392-272B-462A-B03B-FA3F63708993Q39156722-A85988AF-A3B4-4E00-B05C-F986A5B8C88BQ39187306-C6C26B76-2F66-4E77-9D93-3C7D90AB8D6AQ48210380-9E2EF9F5-44F4-4DE0-B2ED-67614D0C1F36Q55139727-5994905B-422F-4471-90D6-EB9B42DFA1F6Q58729712-B750F37B-46AE-45EB-BFF3-DEDC1532166E
P2860
Increased radiosensitivity and radiothermosensitivity of human pancreatic MIA PaCa-2 and U251 glioblastoma cell lines treated with the novel Hsp90 inhibitor NVP-HSP990.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Increased radiosensitivity and ...... el Hsp90 inhibitor NVP-HSP990.
@ast
Increased radiosensitivity and ...... el Hsp90 inhibitor NVP-HSP990.
@en
type
label
Increased radiosensitivity and ...... el Hsp90 inhibitor NVP-HSP990.
@ast
Increased radiosensitivity and ...... el Hsp90 inhibitor NVP-HSP990.
@en
prefLabel
Increased radiosensitivity and ...... el Hsp90 inhibitor NVP-HSP990.
@ast
Increased radiosensitivity and ...... el Hsp90 inhibitor NVP-HSP990.
@en
P2093
P2860
P356
P1433
P1476
Increased radiosensitivity and ...... el Hsp90 inhibitor NVP-HSP990.
@en
P2093
Anca Ligia Grosu
Dušan Milanović
Elke Firat
Gabriele Niedermann
P2860
P2888
P356
10.1186/1748-717X-8-42
P577
2013-02-28T00:00:00Z
P5875
P6179
1035806724